ERBB2 and breast cancer: Both [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3 were capable of visualizing HER2-expressing breast cancer lesions, including primary tumours, lymph node metastases and, in two patients, hepatic metastases.